Overall self-perceived health in Restless legs treated with intrathecal morphine

Acta Neurologica Scandinavica

Volumn 127, Issue 4, 2013, Pages 268-273

  Lindvall, P ^a   Hariz, G M ^a   Blomstedt, P ^a  

^a UMEÅ UNIVERSITY   (Sweden)

Author keywords

Intrathecal morphine; Restless legs; SF 36 health survey; The International Restless Legs Syndrome Severity Scale

Indexed keywords

LEVODOPA; MORPHINE; PRAMIPEXOLE; TRAMADOL;

ADULT; AGED; ANALGESIA; ARTICLE; CASE REPORT; DISEASE SEVERITY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; EMOTIONALITY; EVENING DOSAGE; FEMALE; HEALTH CARE QUALITY; HUMAN; MALE; MENTAL HEALTH; OUTCOME ASSESSMENT; PREOPERATIVE EVALUATION; QUALITY OF LIFE; RATING SCALE; REMISSION; RESTLESS LEGS SYNDROME; SELF EVALUATION; SHORT FORM 36; SOCIAL STATUS;

AGED; ANALGESICS, OPIOID; FEMALE; HUMANS; INJECTIONS, SPINAL; MALE; MIDDLE AGED; MORPHINE; PROSPECTIVE STUDIES; QUALITY OF LIFE; RESTLESS LEGS SYNDROME; SELF CONCEPT; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 84875056891     PISSN: 00016314     EISSN: 16000404     Source Type: Journal    
DOI: 10.1111/j.1600-0404.2012.01707.x     Document Type: Article

References (28)

1. Ekbom K. Restless legs. Acta Med Scand 1945; (Suppl 158):1-123.
2. Allen RP, Earley CJ. Restless legs syndrome: a review of clinical and pathophysiologic features. J Clin Neurophysiol 2001;18:128-47.
3. Innes KE, Selfe TK, Agarwal P. Prevalence of restless legs syndrome in North American and Western European populations: a systematic review. Sleep Med 2011;12:623-34.
4. Earley CJ. Clinical practice. Restless legs syndrome. N Engl J Med 2003;348:2103-9.
5. Abetz L, Allen R, Follet A et al. Evaluating the quality of life of patients with restless legs syndrome. Clin Ther 2004;26:925-35.
6. Kohnen R, Allen RP, Benes H et al. Assessment of restless legs syndrome-methodological approaches for use in practice and clinical trials. Movement disorders: official journal of the Movement Disorder Society 2007;22(Suppl 18):S485-94.
7. Ware JE Jr, Gandek B. Overview of the SF-36 Health Survey and the International Quality of Life Assessment (IQOLA) Project. J Clin Epidemiol 1998;51:903-12.
8. Becker PM. The biopsychosocial effects of restless legs syndrome (RLS). Neuropsychiatr Dis Treat 2006;2:505-12.
9. O'keeffe ST, Noel J, Lavan JN. Restless legs syndrome in the elderly. Postgrad Med J 1993;69:701-3.
10. Jakobsson B, Ruuth K. Successful treatment of restless legs syndrome with an implanted pump for intrathecal drug delivery. Acta Anaesthesiol Scand 2002;46:114-7.
11. Lindvall PK, Ruuth K, Jakobsson B, Nilsson SK. Intrathecal morphine infusion a possible treatment in restless legs. Lakartidningen 2007;104:2250-2.
12. Ross DA, Narus MS, Nutt JG. Control of medically refractory restless legs syndrome with intrathecal morphine: case report. Neurosurgery 2008;62:E263; discussion E.
13. Allen RP, Picchietti D, Hening WA, Trenkwalder C, Walters AS, Montplaisi J. Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health. Sleep Med 2003;4:101-19.
14. Walters AS, Lebrocq C, Dhar A et al. Validation of the International Restless Legs Syndrome Study Group rating scale for restless legs syndrome. Sleep Med 2003;4:121-32.
15. Mchorney CA, Ware JE Jr, Lu JF, Sherbourne CD. The MOS 36-item Short-Form Health Survey (SF-36): III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups. Med Care 1994;32:40-66.
16. Allen RP, Stillman P, Myers AJ. Physician-diagnosed restless legs syndrome in a large sample of primary medical care patients in western Europe: prevalence and characteristics. Sleep Med 2010;11:31-7.
17. Trenkwalder C, Hening WA, Montagna P et al. Treatment of restless legs syndrome: an evidence-based review and implications for clinical practice. Mov Disord 2008;23:2267-302.
18. Ondo WG. Intravenous iron dextran for severe refractory restless legs syndrome. Sleep Med 2010;11:494-6.
19. Yeh P, Walters AS, Tsuang JW. Restless legs syndrome: a comprehensive overview on its epidemiology, risk factors, and treatment. Sleep Breath 2011 [Epub ahead of print].
20. Koulousakis A, Kuchta J, Bayarassou A, Sturm V. Intrathecal opioids for intractable pain syndromes. Acta Neurochir Suppl 2007;97:43-8.
21. Njee TB, Irthum B, Roussel P, Peragut JC. Intrathecal morphine infusion for chronic non-malignant pain: a multiple center retrospective survey. Neuromodulation 2004;7:249-59.
22. Follett KA, Naumann CP. A prospective study of catheter-related complications of intrathecal drug delivery systems. J Pain Symptom Manage 2000;19:209-15.
23. Raffaeli W, Marconi G, Fanelli G, Taddei S, Borghi GB, Casati A. Opioid-related side-effects after intrathecal morphine: a prospective, randomized, double-blind dose-response study. Eur J Anaesthesiol 2006;23:605-10.
24. Ruan X, Couch JP, Liu H, Shah RV, Wang F, Chiravuri S. Respiratory failure following delayed intrathecal morphine pump refill: a valuable, but costly lesson. Pain Physician 2010;13:337-41.
25. Scherens A, Kagel T, Zenz M, Maier C. Long-term respiratory depression induced by intrathecal morphine treatment for chronic neuropathic pain. Anesthesiology 2006;105:431-3.
26. Winkelmuller M, Winkelmuller W. Long-term effects of continuous intrathecal opioid treatment in chronic pain of nonmalignant etiology. J Neurosurg 1996;85:458-67.
27. Lindvall P, Ruuth K, Jakobsson B, Nilsson S. Intrathecal morphine as a treatment for refractory restless legs syndrome. Neurosurgery 2008;63:E1209; author reply E.
28. Sullivan M, Karlsson J, Taft C. Swedish manual and interpretation guide. Gothenburg: Sahlgrenska University Hospital, 2002.